In 2023, the incidence of Tuberculosis, including HIV-positive cases, in France stood at 340 cases per hundred persons. Forecasts from 2024 to 2028 suggest a gradual decline in the number of cases, from 330 in 2024 to an estimated 300 by 2028. This represents a year-on-year decrease of approximately 3% in 2024 and 2025, stabilizing in 2026 and 2027 before decreasing again slightly in 2028. The compound annual growth rate (CAGR) over this period averages out to a decline of approximately 2.4% per year.
Future trends to watch for include the impact of healthcare policies on tuberculosis management and potential changes in the HIV epidemic, as these could influence incidence rates. Additionally, monitoring global public health initiatives and innovations in TB treatment and prevention is crucial, as they could accelerate the decline in cases.
